Zhuhai Kerui Biotechnology: difference between revisions
Diff·revision 15 → 16·18:07, 19 Jul 2025
Difference between revision 15 and revision 16 of Zhuhai Kerui Biotechnology. 3 lines changed; the page grew by 519 bytes.
| Revision 15 — 16:04, 14 Jul 2025 VerifyVesna (talk) de-orphan 4,843 bytes ±0 | Revision 16 — 18:07, 19 Jul 2025 FormularyFrida (talk) tag [citation needed] 5,362 bytes +519 | ||
|---|---|---|---|
| 30 | Reports describe lyophilised material in crimped glass vials with a batch certificate reporting purity, appearance and, in most of the submitted set, a water content.{{r|reports}} Insulated packaging with a gel pack is described for the incretin lines. | 30 | Reports describe lyophilised material in crimped glass vials with a batch certificate reporting purity, appearance and, in most of the submitted set, a water content.{{r|reports}} Insulated packaging with a gel pack is described for the incretin lines. |
| 31 | 31 | ||
| + | 32 | One documentation practice recorded across several reports is worth noting: certificates in this set have named the analytical method and column, which is uncommon. A purity figure with a stated method is more useful than one without, because [[Area percent purity|area percent]] depends on the separation that produced it.{{r|usp1503}} | |
| + | 33 | ||
| 32 | == References == | 34 | == References == |
| 33 | {{reflist}} | 35 | {{reflist}} |
| ⋮ | ⋮ | ||
| 36 | <ref name="reports">Independent test reports submitted to PeptidePedia by purchasers, 2024–2026. Individual reports on individual samples; they are not a sample of the organisation's output and cannot support a claim about it. See [[Blind sampling]].</ref> | 38 | <ref name="reports">Independent test reports submitted to PeptidePedia by purchasers, 2024–2026. Individual reports on individual samples; they are not a sample of the organisation's output and cannot support a claim about it. See [[Blind sampling]].</ref> |
| 37 | <ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref> | 39 | <ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref> |
| + | 40 | <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, "Quality Attributes of Synthetic Peptide Drug Substances" (informational). USP–NF, current revision.</ref> | |
| 38 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> | 41 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> |
| 39 | 42 |